FDA: Transducer Test A Key Element In Ultrasound Guidance

The US agency lifted 510(k) requirements for many diagnostic ultrasounds via a June guidance document. But a new focus on transducer element safety is still posing some challenges, FDA staff said during a recent webinar on the policy changes.

Scanner

Past adverse events prompted the US Food and Drug Administration to recommend additional transducer checks in a recent ultrasound guidance document, an agency official said during a recent webinar.

Shahram Vaezy, a biomedical engineer in the FDA’s Center for Devices and Radiological Health (CDRH), discussed “Marketing Clearance of Diagnostic Ultrasound Systems and Transducers” during the Aug. 22 session. The guidance document is notable for dropping 510(k) requirements for many modifications to ultrasound devices

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Diagnostic Imaging

More from Diagnostics